GI Bleeding Risk of DOACs Versus Warfarin: Is Newer Better?

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2018 Apr 20

PMID 29671162

Citations 5

Authors

Linda A Feagins

Rick A Weideman

Affiliations

Soon will be listed here.

Citing Articles

Construction of a risk scoring system using clinical factors and polymorphisms for bleeding complications in patients on direct oral anticoagulants.

Jang E, Kim J, Choi S, Yee J, Song T, Park J Front Pharmacol. 2023; 14:1290785.

PMID: 38034995 PMC: 10684747. DOI: 10.3389/fphar.2023.1290785.

Gastrointestinal bleeding risk of non-vitamin K antagonist oral anticoagulants versus warfarin in general and after polypectomy: a population-based study with propensity score matching analysis.

Pae J, Kim E, Kim S, Jung M, Heo J, Lee J Intest Res. 2022; 20(4):482-494.

PMID: 35417935 PMC: 9650329. DOI: 10.5217/ir.2021.00161.

Apixaban vs. Warfarin in Atrial Fibrillation Patients With Chronic Kidney Disease.

Fu C, Li L, Lee Y, Wang S, Hsu C Front Cardiovasc Med. 2021; 8:752468.

PMID: 34733897 PMC: 8558356. DOI: 10.3389/fcvm.2021.752468.

Major gastrointestinal bleeding and antithrombotics: Characteristics and management.

Bouget J, Viglino D, Yvetot Q, Oger E World J Gastroenterol. 2020; 26(36):5463-5473.

PMID: 33024397 PMC: 7520611. DOI: 10.3748/wjg.v26.i36.5463.

Preventable Cases of Oral Anticoagulant-Induced Bleeding: Data From the Spontaneous Reporting System.

Mascolo A, Ruggiero R, Sessa M, Scavone C, Sportiello L, Rafaniello C Front Pharmacol. 2019; 10:425.

PMID: 31114497 PMC: 6503045. DOI: 10.3389/fphar.2019.00425.

References

Cohen D . Dabigatran: how the drug company withheld important analyses. BMJ. 2014; 349:g4670. DOI: 10.1136/bmj.g4670. View

Giugliano R, Ruff C, Braunwald E, Murphy S, Wiviott S, Halperin J . Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013; 369(22):2093-104. DOI: 10.1056/NEJMoa1310907. View

Reilly P, Lehr T, Haertter S, Connolly S, Yusuf S, Eikelboom J . The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy). J Am Coll Cardiol. 2013; 63(4):321-8. DOI: 10.1016/j.jacc.2013.07.104. View

Kolb J, Flack K, Chatterjee-Murphy P, Desai J, Wallentin L, Ezekowitz M . Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran. Dig Dis Sci. 2018; 63(7):1878-1889. DOI: 10.1007/s10620-018-5007-6. View

Barnes G, Lucas E, Alexander G, Goldberger Z . National Trends in Ambulatory Oral Anticoagulant Use. Am J Med. 2015; 128(12):1300-5.e2. PMC: 4658248. DOI: 10.1016/j.amjmed.2015.05.044. View

Cangemi D, Krill T, Weideman R, Cipher D, Spechler S, Feagins L . A Comparison of the Rate of Gastrointestinal Bleeding in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin. Am J Gastroenterol. 2017; 112(5):734-739. DOI: 10.1038/ajg.2017.39. View

Brodie M, Newman J, Smith T, Rockey D . Severity of Gastrointestinal Bleeding in Patients Treated with Direct-Acting Oral Anticoagulants. Am J Med. 2017; 131(5):573.e9-573.e15. DOI: 10.1016/j.amjmed.2017.11.007. View

Connolly S, Ezekowitz M, Yusuf S, Eikelboom J, Oldgren J, Parekh A . Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009; 361(12):1139-51. DOI: 10.1056/NEJMoa0905561. View

Southworth M, Reichman M, Unger E . Dabigatran and postmarketing reports of bleeding. N Engl J Med. 2013; 368(14):1272-4. DOI: 10.1056/NEJMp1302834. View

10.

Abraham N, Singh S, Alexander G, Heien H, Haas L, Crown W . Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study. BMJ. 2015; 350:h1857. PMC: 4413863. DOI: 10.1136/bmj.h1857. View

11.

Granger C, Alexander J, McMurray J, Lopes R, Hylek E, Hanna M . Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011; 365(11):981-92. DOI: 10.1056/NEJMoa1107039. View

12.

Patel M, Mahaffey K, Garg J, Pan G, Singer D, Hacke W . Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011; 365(10):883-91. DOI: 10.1056/NEJMoa1009638. View

13.

Feagins L . Management of Anticoagulants and Antiplatelet Agents During Colonoscopy. Am J Med. 2017; 130(7):786-795. DOI: 10.1016/j.amjmed.2017.01.052. View